$JIANGXI BIO(06915.HK) is up? Huh?
Write something you'd like to share with our community...
$JIANGXI BIO(06915.HK) is up? Huh?

JIANGXI BIO
HK06915
$ZAI LAB(09688.HK), $CSTONE PHARMA-B(02616.HK) have always had a seat at the table for out-licensing, while $TH MEDICAL-B(02697.HK), $LONGBIO-B(01779.HK), $JIANGXI BIO(06915.HK) — this batch of B-suffix companies are still grinding through clinical trials. As the story of innovative drugs unfolds this year, patience is more valuable than vision 🥲
$WUXI BIO(02269.HK) rose nearly four percentage points, as Hong Kong's CXO sector followed the recovery in global R&D outsourcing demand; $REMEGEN(09995.HK), $3SBIO(01530.HK), and $JIANGXI BIO(06915.HK) all fell between one and four percentage points, with innovative drugs and biologics seeing profit-taking.
$TH MEDICAL-B(02697.HK) has a different logic, falling over three percentage points. It focuses on surgical robots and medical devices, relying on product volume rather than pipeline data. Both are under the healthcare sector, but the shovel-selling CXO is rising while the pipeline-betting innovative drugs are falling. In this divergence, which side would you rather stand on? I lean towards CXO—the certainty of cash flow is more valuable in a market lacking catalysts.
$JIANGXI BIO(06915.HK) Does this thing have a bottom?

JIANGXI BIO
HK06915
$TONGRENTANGCARE(02667.HK) won't go the same way as Jiangxi Bio and head for a 50% drop, will it?
$JIANGXI BIO(06915.HK)Scary😱, directly halved

JIANGXI BIO
HK06915
$JIANGXI BIO(06915.HK) is selling the company

JIANGXI BIO
HK06915
Hello, I'm Lu Xian. I research the investment field and share overseas information. The previous post shared about Jiangxi Bio, and today let's look at a leading consumer electronics company that is going for a Hong Kong listing from the A-share market—Luxshare Precision. The company has been listed on the A-share market for many years, with consumer electronics as its core business, while expanding into the automotive electronics and data center sectors. This issuance is of a large scale, with a focus on the A/H discount, cornerstone lock-up, and post-listing capital absorption...


$JIANGXI BIO(06915.HK) CICC's green shoe must not be touched...

JIANGXI BIO
HK06915
$JIANGXI BIO(06915.HK) Can it just go up for one day?

JIANGXI BIO
HK06915
$JIANGXI BIO(06915.HK) So shameless?

JIANGXI BIO
HK06915
$JIANGXI BIO(06915.HK) The green shoe isn't moving at all?

JIANGXI BIO
HK06915
$JIANGXI BIO(06915.HK)Green shoe not triggered?

JIANGXI BIO
HK06915
$JIANGXI BIO(06915.HK) What's going on?

JIANGXI BIO
HK06915
$JIANGXI BIO(06915.HK) The green shoe only appeared intraday on Tuesday.

$JIANGXI BIO(06915.HK) Everyone, wishing you prosperity, sold at 10.5. Working hard to return to the issue price.


JIANGXI BIO
HK06915
$JIANGXI BIO(06915.HK) Is this trying to pull back up? Has the greenshoe been exercised?

JIANGXI BIO
HK06915